Aurora Cannabis
Aurora Cannabis · page 2
- Markets & Stocks
Aurora Posts Record Quarter Thanks to European Medical Growth, Little Green Pharma Acquires Health House, & More From Argent Bio.
Aurora Cannabis [stock_market_widget type=”chart” template=”line” assets=”ACB” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Canadian cannabis giant Aurora Cannabis has seen its stock jump nearly 50% this week after publishing a record-breaking financial performance in its third quarter.
- Events
International Experts Gather to Shape the Future of Cannabis Legislation at the Inaugural Global Cannabis Regulatory Summit
A comprehensive cross-section of the world’s most influential policymakers and global regulatory officials are set to meet with a group of the cannabis industry’s leading voices for an unprecedented inaugural global summit.
- Uncategorized
Canadian Cannabis Sales Continue Turbulent Year With 2% Downturn in June
Canadian cannabis sales have continued their mixed performance through June 2024, seeing another dip in total sales, but some states are showing resilience.
- Medical
2023 Spotlight: France’s Battle for Medical Cannabis
2023 has been a milestone year for European cannabis. Europe’s first fully legal adult-use cannabis stores have opened in Switzerland.
- Uncategorized
Aurora Hails ‘Strongest Fiscal Year to Date’ As Medical Cannabis Sales to Europe Bolster Balance Sheet
The Canadian cannabis giant Aurora Cannabis published its second quarter results last week, revealing a double-digit jump in revenues and record pre-tax profits.
- Companies
Aurora Cannabis reports $87 million loss, aims for positive free cash flow
Aurora Cannabis reports $87 million loss, aims for positive free cash flow Aurora Cannabis’ financial woes have continued in the first quarter of 2023, with the Canadian cannabis giant posting increasing net losses despite a slight bump in revenues.
